Gabriele Antonarelli

8PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 15, 2026
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Carmine Valenza, Yue Zheng, Monica Milano

|Apr 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial.

Antonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló

|Jan 23, 2024
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting.

Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti

|Mar 29, 2023
Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation.

Gabriele Antonarelli, Valentina Pieri, Francesca Maria Porta

|Feb 11, 2023
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment.

Carmine Valenza, Beatrice Taurelli Salimbeni, Celeste Santoro

|Sep 09, 2022
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies.

Carmen Belli, Gabriele Antonarelli, Matteo Repetto

Pageof 2

Frequent Collaborators

7 joint publications

Giuseppe Curigliano

3 joint publications

Carmen Belli

2 joint publications

Paolo Tarantino

2 joint publications

Carmen Criscitiello